Benitec Biopharma (BNTC) Exchange Rate Effect (2019 - 2025)
Benitec Biopharma (BNTC) posted Exchange Rate Effect of -$132000.0 for Q4 2025, down 253.49% sequentially from $86000.0 in Q3 2025, and down 238.95% YoY from $95000.0 in Q4 2024.
Benitec Biopharma (BNTC) Exchange Rate Effect (2019 - 2025) Analysis & Trends
Benitec Biopharma has reported Exchange Rate Effect for 7 years, with the latest figure at -$132000.0 in Q4 2025.
- Quarterly Exchange Rate Effect fell 238.95% year-over-year to -$132000.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $3000.0 (down 97.27% YoY) and the FY2025 annual result came in at $49000.0, up 712.5% from the prior year.
- Exchange Rate Effect eased to -$132000.0 in Q4 2025 per BNTC's latest filing, from $86000.0 in the prior quarter.
- Over five years, Exchange Rate Effect peaked at $501000.0 in Q3 2022 and troughed at -$277000.0 in Q1 2022.
- A 5-year average of $35950.0 and a median of $32000.0 in 2023 frame the typical range for Exchange Rate Effect.
- The widest YoY moves for Exchange Rate Effect: up 190.53% in 2025, down 2300.0% in 2025.
- Over 5 years, Exchange Rate Effect stood at -$54000.0 in 2021, then tumbled by 183.33% to -$153000.0 in 2022, then fell by 6.54% to -$163000.0 in 2023, then soared by 158.28% to $95000.0 in 2024, then plunged by 238.95% to -$132000.0 in 2025.
- According to Business Quant data, Exchange Rate Effect over the past three periods registered -$132000.0, $86000.0, and -$120000.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Exchange Rate Effect (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | -3.70 Mn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | -300,000.00 |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 19.84 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | -14,590.12 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | -2.45 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | -287,000.00 |
| 10 | Benitec Biopharma | 577.39 Mn | 388.49 Mn | - | -132,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -132,000.00 |
| Dec 31, 2025 | -132,000.00 |
| Sep 30, 2025 | 86,000.00 |
| Sep 30, 2025 | 86,000.00 |
| Jun 30, 2025 | -120,000.00 |
| Jun 30, 2025 | -120,000.00 |
| Mar 31, 2025 | 169,000.00 |
| Mar 31, 2025 | 169,000.00 |
| Dec 31, 2024 | 95,000.00 |
| Dec 31, 2024 | 95,000.00 |
| Sep 30, 2024 | -95,000.00 |
| Sep 30, 2024 | -95,000.00 |
| Jun 30, 2024 | -5,000.00 |
| Jun 30, 2024 | -5,000.00 |
| Mar 31, 2024 | 115,000.00 |
| Mar 31, 2024 | 115,000.00 |
| Dec 31, 2023 | -163,000.00 |
| Dec 31, 2023 | -163,000.00 |
| Sep 30, 2023 | 45,000.00 |
| Sep 30, 2023 | 45,000.00 |